Eisner Mark
SEC CIK 1834161 · EDGAR
BoughtSold
Most active insiders at VIR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | SVF Endurance (Cayman) Ltd | 10% | — | $9.38M |
| 2 | SB INVESTMENT ADVISERS (UK) LTD | 10% | — | $5.72M |
| 3 | SOFTBANK VISION FUND (AIV M1) L.P. | 10% | — | $2.76M |
| 4 | SATO VICKI L | Dir | — | $1.73M |
| 5 | De Backer Marianne | Pres, CEO, Dir | — | $946.9K |
| 6 | de Verneuil Vanina | EVP, GC, Corp Sec | — | $217.7K |
| 7 | Sabatini Brent | SVP, CAO | — | $113.1K |
| 8 | O'Byrne Jason | EVP, CFO | — | $68.9K |
| 9 | Eisner Mark | EVP, Chief Medical Off | — | $49.5K |
| 10 | Napolitano Janet | Dir | — | $30.2K |
Transactions 25
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-02-26 | 2026-02-24+ | VIR | Vir Biotechnology, Inc. | Eisner Mark | EVP, Chief Medical Off | S - Sale | $9.69 | -3,505 | 155.9K | -2% | -$34.0K |
| D | 2026-02-24 | 2026-02-22 | VIR | Vir Biotechnology, Inc. | Eisner Mark | EVP, Chief Medical Off | A - Grant | $0.00 | +55.0K | 159.6K | +53% | $0 |
| D | 2026-02-24 | 2026-02-23 | VIR | Vir Biotechnology, Inc. | Eisner Mark | EVP, Chief Medical Off | S - Sale | $7.45 | -2,089 | 157.5K | -1% | -$15.6K |
| M | 2025-07-17 | 2025-07-15+ | VIR | Vir Biotechnology, Inc. | Eisner Mark | EVP, Chief Medical Off | S - Sale | $5.47 | -10.4K | 108.2K | -9% | -$56.8K |
| D | 2025-02-25 | 2025-02-22 | VIR | Vir Biotechnology, Inc. | Eisner Mark | EVP, Chief Medical Off | A - Grant | $0.00 | +40.0K | 115.0K | +53% | $0 |
| D | 2024-07-16 | 2024-07-15 | VIR | Vir Biotechnology, Inc. | Eisner Mark | EVP, Chief Medical Off | A - Grant | $0.00 | +75.0K | 75.0K | New | $0 |
| 2023-09-08 | 2023-09-06 | KYNB | KYNTRA BIO, INC. | Eisner Mark | EVP, Chief Medical Off | F - Tax | $0.96 | -1,860 | 159.9K | -1% | -$1,786 | |
| 2023-09-06 | 2023-09-01 | KYNB | KYNTRA BIO, INC. | Eisner Mark | EVP, Chief Medical Off | F - Tax | $1.06 | -1,085 | 161.8K | -0.7% | -$1,150 | |
| 2023-06-09 | 2023-06-07 | KYNB | KYNTRA BIO, INC. | Eisner Mark | EVP, Chief Medical Off | S - Sale | $17.04 | -2,042 | 162.9K | -1% | -$34.8K | |
| 2023-06-05 | 2023-06-02 | KYNB | KYNTRA BIO, INC. | Eisner Mark | EVP, Chief Medical Off | S - Sale | $18.83 | -1,090 | 164.9K | -0.7% | -$20.5K | |
| 2023-04-06 | 2023-04-04 | KYNB | KYNTRA BIO, INC. | Eisner Mark | Chief Medical Off | S - Sale | $18.78 | -9,182 | 166.0K | -5% | -$172.4K | |
| M | 2023-03-10 | 2023-03-08 | KYNB | KYNTRA BIO, INC. | Eisner Mark | Chief Medical Off | A - Grant | $0.00 | +20.2K | 185.3K | +12% | $0 |
| M | 2023-03-10 | 2023-03-08+ | KYNB | KYNTRA BIO, INC. | Eisner Mark | Chief Medical Off | S - Sale | $20.60 | -17.5K | 165.1K | -10% | -$360.6K |
| 2023-03-06 | 2023-03-02 | KYNB | KYNTRA BIO, INC. | Eisner Mark | Chief Medical Off | S - Sale | $21.87 | -1,187 | 172.5K | -0.7% | -$26.0K | |
| D | 2023-02-23 | 2023-02-21 | KYNB | KYNTRA BIO, INC. | Eisner Mark | Chief Medical Off | A - Grant | $0.00 | +32.5K | 173.7K | +23% | $0 |
| 2022-12-02 | 2022-12-01 | KYNB | KYNTRA BIO, INC. | Eisner Mark | Chief Medical Off | F - Tax | $15.04 | -1,084 | 141.2K | -0.8% | -$16.3K | |
| 2022-10-04 | 2022-09-30 | KYNB | KYNTRA BIO, INC. | Eisner Mark | Chief Medical Off | F - Tax | $13.01 | -6,777 | 142.3K | -5% | -$88.2K | |
| 2022-09-02 | 2022-09-01 | KYNB | KYNTRA BIO, INC. | Eisner Mark | Chief Medical Off | F - Tax | $13.09 | -756 | 149.0K | -0.5% | -$9,896 | |
| 2022-06-03 | 2022-06-01 | KYNB | KYNTRA BIO, INC. | Eisner Mark | Chief Medical Off | F - Tax | $9.61 | -1,141 | 149.8K | -0.8% | -$11.0K | |
| 2022-04-01 | 2022-03-31 | KYNB | KYNTRA BIO, INC. | Eisner Mark | Chief Medical Off | F - Tax | $12.02 | -6,442 | 150.9K | -4% | -$77.4K | |
| 2022-03-03 | 2022-03-01 | KYNB | KYNTRA BIO, INC. | Eisner Mark | Chief Medical Off | F - Tax | $13.62 | -756 | 157.4K | -0.5% | -$10.3K | |
| D | 2022-02-16 | 2022-02-14 | KYNB | KYNTRA BIO, INC. | Eisner Mark | Chief Medical Off | A - Grant | $0.00 | +60.0K | 158.1K | +61% | $0 |
| 2022-01-05 | 2022-01-03 | KYNB | KYNTRA BIO, INC. | Eisner Mark | Chief Medical Off | F - Tax | $14.82 | -7,043 | 98.1K | -7% | -$104.4K | |
| 2021-12-03 | 2021-12-01 | KYNB | KYNTRA BIO, INC. | Eisner Mark | Chief Medical Off | F - Tax | $12.65 | -4,338 | 105.2K | -4% | -$54.9K | |
| D | 2021-10-06 | 2021-10-04 | KYNB | KYNTRA BIO, INC. | Eisner Mark | Chief Medical Off | A - Grant | $0.00 | +74.5K | 109.5K | +213% | $0 |
Purchase Sale Sale after option exercise All abbreviations